Bon Natural Life Ltd
Datakwaliteit: 100%
BON
NASDAQ
Manufacturing
Chemicals
€ 1,30
▲
€ 0,01
(0,78%)
6 months return
—
Momentum
Neutral
5Y revenue growth
-7,49%
Groei
Revenue Growth (5Y)
-7,49%
Onder sectorgemiddelde (1,82%)
Revenue (1Y)-21,70%
Earnings (1Y)-600,98%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-3,93%
Boven sectorgemiddelde (-54,47%)
ROIC-2,13%
Net Margin-10,68%
Op. Margin-8,69%
Veiligheid
Debt / Equity
0,46
Boven sectorgemiddelde (0,30)
Current Ratio1,11
Interest Coverage-4,43
Waardering
PE (TTM|NTM)
-6,68 | 2,26
Onder sectorgemiddelde (-1,49)
P/B Ratio0,98
EV/EBITDAN/A
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Revenue declined -7,49% annually over 5 years
Earnings declined -600,98% over the past year
Debt/Equity of 0,46 — conservative balance sheet
Generating 134.288,0 in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 14,21%
Capital efficient — spends only 0,04% of revenue on capex
Price History
Financiële Trends
Koersdoel Analisten
Geen analistendekking beschikbaar
Growth
Rev 5Y: -7,49% · Earnings 1Y: -600,98%
Growth
Rev 5Y: -7,49% · Earnings 1Y: -600,98%| Revenue Growth (1Y) | -21,70% | Revenue Growth (3Y) | -20,47% |
| Earnings Growth (1Y) | -600,98% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -7,49% | Earnings Growth (5Y) | N/A |
Profitability
ROE: -3,93% · Net Margin: -10,68%
Profitability
ROE: -3,93% · Net Margin: -10,68%| Revenue (TTM) | 18,67 M | Net Income (TTM) | -1,99 M |
| ROE | -3,93% | ROA | -2,71% |
| Gross Margin | 20,77% | Operating Margin | -8,69% |
| Net Margin | -10,68% | Free Cash Flow (TTM) | 134.288,0 |
| ROIC | -2,13% | FCF Growth (3Y) | N/A |
Safety
D/E: 0,46 · Current: 1,11
Safety
D/E: 0,46 · Current: 1,11| Debt / Equity | 0,46 | Current Ratio | 1,11 |
| Interest Coverage | -4,43 | Asset Turnover | 0,25 |
| Working Capital | 1,43 M | Tangible Book Value | 13,40 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: -6,68 · EV/EBITDA: N/A
Valuation
P/E: -6,68 · EV/EBITDA: N/A| P/E Ratio | -6,68 | Forward P/E | 2,26 |
| P/B Ratio | 0,98 | P/S Ratio | 0,71 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | 44,25% |
| FCF Yield | 1,01% | ||
| Market Cap | 13,32 M | Enterprise Value | 19,57 M |
Per Share
EPS: -0,72 · FCF/Share: 0,01
Per Share
EPS: -0,72 · FCF/Share: 0,01| EPS (Diluted TTM) | -0,72 | Revenue / Share | 1,84 |
| FCF / Share | 0,01 | OCF / Share | 0,01 |
| EPS CAGR (1Y) | -523,53% | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: -6,73% · CapEx/Rev: 0,04%
Efficiency
FCF Conv: -6,73% · CapEx/Rev: 0,04%| CapEx / Revenue | 0,04% | FCF Conversion | -6,73% |
| SBC-Adj. FCF | -1,26 M | Growth Momentum | -14,21 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 18,67 M | 23,84 M | 29,52 M | 29,91 M | 25,49 M |
| Net Income | -1,99 M | 398.172,0 | 4,60 M | 6,24 M | 4,59 M |
| EPS (Diluted) | -0,72 | 0,17 | 0,50 | 0,74 | 0,68 |
| Gross Profit | 3,88 M | 7,11 M | 8,84 M | 9,42 M | 7,11 M |
| Operating Income | -1,62 M | 1,87 M | 5,92 M | 6,54 M | 5,40 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 754.193,0 | 1,62 M | 298.469,0 | 424.558,0 | 249.050,0 |
| SG&A Expenses | — | — | — | — | — |
| D&A | 1,09 M | 1,11 M | 954.517,0 | 218.526,0 | 228.547,0 |
| Interest Expense | 366.180,0 | 303.325,0 | 238.224,0 | 446.884,0 | 417.266,0 |
| Income Tax | 339.414,0 | 351.179,0 | 1,00 M | 1,27 M | 820.931,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 85,19 M | 61,77 M | 46,56 M | 37,26 M | 36,41 M |
| Total Liabilities | 27,19 M | 17,42 M | 10,57 M | 7,16 M | 9,88 M |
| Shareholders' Equity | 57,55 M | 43,91 M | 35,48 M | 29,56 M | 26,01 M |
| Total Debt | 12,17 M | 7,15 M | 3,80 M | 4,75 M | 2,66 M |
| Cash & Equivalents | — | 80.466,0 | — | — | — |
| Current Assets | 45,76 M | 39,79 M | 24,18 M | 14,72 M | 16,55 M |
| Current Liabilities | 26,31 M | 16,45 M | 9,61 M | 6,65 M | 7,53 M |
Sectorvergelijking
vs Manufacturing sector mediaan (1605 peers)
Vergeleken met vergelijkbare bedrijven in Manufacturing
Sectorvergelijking
vs Manufacturing sector mediaan (1605 peers) Vergeleken met vergelijkbare bedrijven in Manufacturing| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -6,7 | -1,5 |
| P/B | 1,0 | 1,6 |
| ROE % | -3,9 | -54,5 |
| Net Margin % | -10,7 | -41,5 |
| Rev Growth 5Y % | -7,5 | 1,8 |
| D/E | 0,5 | 0,3 |
Strategiescores
1 strategy matched
Strategiescores
1 strategy matched
#162 of 172
Recente Activiteit
Ingestapt
Deep Value Investing (Seth Klarman)
Apr 12, 2026
{"event":"ticker_viewed","properties":{"ticker":"BON","listing_kind":"stock","pathname":"/stocks/bon","exchange":"NASDAQ","country":"US"}}
